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217 (5) (9) . The anemia does not result from reduced activity of hem .e biosynthetic en2 (11) . On the other hand, several abnormalities in ymes iron metabolism are observed. These include: 1) defective iron absorption, 2) an inability to transfer iron from damaged erythrocytes to plasma at a normal rate, and 3) increased deposition of iron in reticuloendothelial and hepatic parenchymal cells. These abnormalities have been shown to be due to an inability to transfer iron from cells to plasma (10). The copper-containing serum globulin, ceruloplasmin, has been reported by Curzon and O'Reilly (6) to catalyze the oxidation of ferrous iron in vitro. Osaki and co-workers (16) confirmed and extended these observations and suggested that, by this mechanism, ceruloplasmin may play a biological role in the transfer of iron from cells to plasma transferrin.
The following assumptions are implicit in their hypothesis:
1) that iron is presented to plasma in the form of ferrous iron, 2) that oxidation to the ferric form is necessary for optimal binding by plasma transferrin, and 3) that the rate of iron oxidation in the absence of ceruloplasmin is not adequate to meet the demands of the erythroid bone marrow for iron. If the hypothesis is correct, a defect in this mechanism could account for many of the abnormalities seen in copper-deficient swine. The purpose of the present studies was to evaluate the hypothesis in an in vivo system.
In previously reported studies, the intravenous administration of 0.1 mg of inorganic copper per kilogram of body weight to copper-deficient swine was followed by an increase in the plasma iron concentration (10). This phenomenon might have been due either to a direct effect of the administered copper or to an effect of the ceruloplasmin synthesized therefrom. A preliminary study of the time relations between the change in plasma iron and plasma ceruloplasmin following the above dose of copper failed to distinguish between these two possibilities.
The studies to be reported employed a smaller dose of inorganic copper, one that induced no measurable change in plasma ceruloplasmin.
The effects of such an injection were compared with the effect of the same amount of copper in the form of ceruloplasmin.
A preliminary report of this work has been published elsewhere (12) .
METHODS
Fifteen 4-day-old pigs were obtained from a single supplier. All were maintained for at least 70 days on a copperand iron-deficient diet consisting of canned, condensed milk (9). In addition, each pig was given a total of 2.0 g of iron as iron dextrin (Pigdex) in multiple intramuscular injections between 5 and 30 days of age. No other source available to them throu ghout the study period.
of iron was
The pigs were divided into three groups. Those in group I (seven animals) initially were given ceruloplasmin. After 8-10 days, when changes due to the initial injection were no longer apparent, four of these pigs were given copper sulfate. Pigs in group II (six animals) were given copper sulfate initially and four of these were given ceruloplasmin 8-10 days later. Thus there were 11 studies in which ceruloplasmin was given and 10 studies with inorganic copper. The effect of the administered agent was the same whether given as the initial or subsequent injection.
Group II. consisted of two pigs which were given plasma from a copper-deficient pig as a control of nonspecific effects of homologous protein administration.
The administered dose of ceruloplasmin copper or of copper sulfate was rel .ated to estimated plasma volume (3), rather than body weight. Each pig was given 15 pg of copper per 100 ml plasma volume through a catheter inserted into the anterior vena cava. On a weight basis, the dose averaged 9.1 pg of copper per kilogram of body weight in both groups I and II and ranged from 7.1 to 13.0 pg/kg in individual pigs because of variations in plasma volume. This dose was selected on the basis of preliminary experiments which indicated that such no appreciable an amount of inorganic copper would ind change in plasma ceruloplasmin levels.
uce Ceruloplasmin used in these studies was prepared by chromatography on diethylaminoethyl Sephadex columns Following the administration of ceruloplasmin, the plasma iron concentration increased promptly, reaching a peak about 4 hr after the injection.
The increased values were sustained for 4 days and then gradually returned toward control levels ( Fig. 1 ). In the pigs given inorganic copper, only a slight increase in plasma iron concentration was observed over the next few hours. At 24 and 48 hr after the injections, the plasma iron concentration was less than that observed prior to the infusion.
The two groups remained significantly different (P < .OOl) with respect to the change in plasma iron concentrations for 5 days. No change in plasma iron concentration was observed over a 6-hr period in either of the pigs given homologous, copperdeficient plasma (Fig. 1) . The rapidity with which ceruloplasmin injection affects plasma iron is shown in Table 2 . The increase in plasma iron in the ceruloplasmin-treated group was apparent in 5 min and plasma iron concentration rose rapidly thereafter. 
RESULTS

Injections
of ceruloplasmin, copper sulfate, or copper-deficient plasma were made after about 70 days on the copperdeficient diet. At this time, all pigs in the experimental groups were profoundly copper deficient, as indicated by the presence of anemia, hypocupremia, and hypoceruloplasminemia (Table  1) . Wide variations in serum iron concentration were found in all groups. No significant differences among the three experimental groups with respect to these measures were found prior to injection. The manifestations of copper deficiency in these pigs did not differ from those reported in more detail elsewhere (10).
With the dose levels used, no increase in plasma ceruloplasmin was detected after the administration of copper sulfate (Fig. 1) and specific activity (O---O) are depicted.
In A, plasma iron outflow (l&J was held constant and plasma iron inflow (Kin) was varied. In B, Kin was held constant and K out was varied. Best match was obtained by manipulations of inflow only (A).
over a 2-hr period to monitor changes in plasma iron concentration and specific activity. These data were then simulated with a computer programmed to calculate time-dependent changes in specific activity and concentration in a pool as a function of altered inflow and outflow rates (2).
The results of a representative study in a single copperdeficient pig given ceruloplasmin are depicted in Fig. 2 . The best match between observed and computer-simulated data was achieved by holding plasma iron outflow constant and increasing inflow (Fig. ZA) . By contrast, a poor match was obtained when inflow was held constant and outflow was decreased (Fig. ZB) . A number of attempts were made to match the data by varying inflow and outflow simultaneously. When a significant change in outflow was combined with an increased inflow, it was possible to simulate the curve for either plasma iron or specific activity, but not both. Therefore, it appears that the primary effect of ceruloplasmin is to increase plasma iron inflow.
DISCUSSION
Defective movement of iron from reticuloendothelial (R-E) cells, hepatic cells, and gastrointestinal mucosa to plasma is a characteristic abnormality in copper-deficient swine (10) . The present studies demonstrate that this defect can be reversed promptly by the intravenous administration of ceruloplasmin.
The effect of ceruloplasmin could not have been due simply to partial correction of the copper-deficient state because inorganic copper, in an amount identical to that contained in the injected ceruloplasmin, induced little or no increase in plasma iron levels.
It should be noted that the most probable source of iron which entered the plasma after ceruloplasmin administration was the R-E and hepatic cells. The gut could not have been a source, since these animals were maintained on an iron-deficient diet. These observations suggest, therefore, that the R-E iron "block" previously demonstrated in copper-deficient swine (10) is a consequence, at least in part, of hypoceruloplasminemia.
They further suggest that ceruloplasmin plays a physiologic role in mediating R-E iron release.
The mechanism of action of ceruloplasmin was not determined in these studies. However, the observations support the concept of ceruloplasmin function proposed by Osaki and associates (16). According to their concept, iron is presented to the cell membrane in the form of ferrous ion. Subsequent binding of iron by plasma transferrin would depend on the rate of oxidation to ferric ion, a rate which is markedly accelerated by ceruloplasmin.
In the absence of ceruloplasmin, the rate of cell-to-plasma iron transfer could be no faster than the autooxidation reaction. The rate of the latter reaction, under physiologic conditions, appears to be inadequate to account for the amount of iron normally passing into plasma (16). In the presence of ceruloplasmin, however, iron oxidation is so rapid that it could not be a rate-limiting step in cellular iron release. Another possible mechanism of action of ceruloplasmin is that it delivers copper to a critical intracellular site more efficiently than does albumin-bound copper and by this means regenerates an intracellular copper enzyme essential for iron release. A defect in such a system could account for the development of the R-E iron Cc block" in copper-deficient swine and for the corrective effect of ceruloplasmin. This mechanism, however, seems unlikely because ceruloplasmin was effective within 5 min after administration (Table 2) and at a time when all of the ceruloplasmin activity and its copper appeared to be in the plasma.
The 
